AU660675B2 - Method for regulating enzyme activities by noble gases - Google Patents
Method for regulating enzyme activities by noble gases Download PDFInfo
- Publication number
- AU660675B2 AU660675B2 AU17116/92A AU1711692A AU660675B2 AU 660675 B2 AU660675 B2 AU 660675B2 AU 17116/92 A AU17116/92 A AU 17116/92A AU 1711692 A AU1711692 A AU 1711692A AU 660675 B2 AU660675 B2 AU 660675B2
- Authority
- AU
- Australia
- Prior art keywords
- gas
- enzyme
- enzymes
- mixture
- noble
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 102000004190 Enzymes Human genes 0.000 title claims description 264
- 108090000790 Enzymes Proteins 0.000 title claims description 264
- 230000000694 effects Effects 0.000 title claims description 141
- 229910052756 noble gas Inorganic materials 0.000 title claims description 109
- 238000000034 method Methods 0.000 title claims description 106
- 150000002835 noble gases Chemical class 0.000 title claims description 68
- 230000001105 regulatory effect Effects 0.000 title claims description 62
- 239000007789 gas Substances 0.000 claims description 289
- 239000000203 mixture Substances 0.000 claims description 141
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 126
- 229910052724 xenon Inorganic materials 0.000 claims description 108
- 239000003570 air Substances 0.000 claims description 102
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 claims description 99
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 87
- 229910052786 argon Inorganic materials 0.000 claims description 73
- 239000001301 oxygen Substances 0.000 claims description 69
- 229910052760 oxygen Inorganic materials 0.000 claims description 69
- 238000006243 chemical reaction Methods 0.000 claims description 68
- 229910052743 krypton Inorganic materials 0.000 claims description 66
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 64
- DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton atom Chemical compound [Kr] DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 claims description 57
- 229910052754 neon Inorganic materials 0.000 claims description 51
- 230000002401 inhibitory effect Effects 0.000 claims description 50
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 claims description 44
- 239000000758 substrate Substances 0.000 claims description 44
- 229910052757 nitrogen Inorganic materials 0.000 claims description 43
- 102000004316 Oxidoreductases Human genes 0.000 claims description 29
- 108090000854 Oxidoreductases Proteins 0.000 claims description 29
- 230000002708 enhancing effect Effects 0.000 claims description 27
- 230000002255 enzymatic effect Effects 0.000 claims description 22
- 102000003960 Ligases Human genes 0.000 claims description 20
- 108090000364 Ligases Proteins 0.000 claims description 20
- 102000004157 Hydrolases Human genes 0.000 claims description 16
- 108090000604 Hydrolases Proteins 0.000 claims description 16
- 102000004317 Lyases Human genes 0.000 claims description 15
- 108090000856 Lyases Proteins 0.000 claims description 15
- 102000004357 Transferases Human genes 0.000 claims description 15
- 108090000992 Transferases Proteins 0.000 claims description 15
- 230000008569 process Effects 0.000 claims description 15
- 102000004195 Isomerases Human genes 0.000 claims description 13
- 108090000769 Isomerases Proteins 0.000 claims description 13
- 239000012159 carrier gas Substances 0.000 claims description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 239000006185 dispersion Substances 0.000 claims description 8
- 238000006911 enzymatic reaction Methods 0.000 claims description 8
- 230000007704 transition Effects 0.000 claims description 8
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 6
- 239000003112 inhibitor Substances 0.000 claims description 6
- 239000011159 matrix material Substances 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 238000000855 fermentation Methods 0.000 claims description 5
- 230000004151 fermentation Effects 0.000 claims description 5
- 239000001569 carbon dioxide Substances 0.000 claims description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 3
- 239000003623 enhancer Substances 0.000 claims description 3
- 238000009007 Diagnostic Kit Methods 0.000 claims description 2
- 229930182555 Penicillin Natural products 0.000 claims description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 235000013405 beer Nutrition 0.000 claims description 2
- 235000013351 cheese Nutrition 0.000 claims description 2
- 229940049954 penicillin Drugs 0.000 claims description 2
- 235000014101 wine Nutrition 0.000 claims description 2
- 230000003115 biocidal effect Effects 0.000 claims 2
- 229940088598 enzyme Drugs 0.000 description 220
- 210000004027 cell Anatomy 0.000 description 162
- 102000003425 Tyrosinase Human genes 0.000 description 125
- 108060008724 Tyrosinase Proteins 0.000 description 125
- 230000005764 inhibitory process Effects 0.000 description 66
- 239000000243 solution Substances 0.000 description 62
- 239000011734 sodium Substances 0.000 description 57
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 49
- 239000000872 buffer Substances 0.000 description 48
- 229960004441 tyrosine Drugs 0.000 description 43
- 210000002966 serum Anatomy 0.000 description 21
- 238000002835 absorbance Methods 0.000 description 17
- 238000002474 experimental method Methods 0.000 description 17
- 239000007787 solid Substances 0.000 description 17
- 101150079778 PREP gene Proteins 0.000 description 15
- 239000011261 inert gas Substances 0.000 description 15
- 229920001296 polysiloxane Polymers 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- UYYRDZGZGNYVBA-VPXCCNNISA-N (2s,3r,4s,5r,6r)-2-[2-chloro-4-[3-(3-chloro-4-hydroxyphenyl)-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C=C(Cl)C(O)=CC=2)C=C1Cl UYYRDZGZGNYVBA-VPXCCNNISA-N 0.000 description 12
- 108010056771 Glucosidases Proteins 0.000 description 11
- 102000004366 Glucosidases Human genes 0.000 description 11
- 102100025490 Slit homolog 1 protein Human genes 0.000 description 10
- 101710123186 Slit homolog 1 protein Proteins 0.000 description 10
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 10
- 238000002347 injection Methods 0.000 description 10
- 239000007924 injection Substances 0.000 description 10
- 239000012064 sodium phosphate buffer Substances 0.000 description 10
- 238000001228 spectrum Methods 0.000 description 10
- 108010078791 Carrier Proteins Proteins 0.000 description 9
- 239000008367 deionised water Substances 0.000 description 9
- 229910021641 deionized water Inorganic materials 0.000 description 9
- 238000011160 research Methods 0.000 description 9
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 8
- 230000003993 interaction Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 230000001766 physiological effect Effects 0.000 description 8
- VKDJIPBMRCGQMQ-UHFFFAOYSA-N argon krypton xenon Chemical compound [Ar].[Kr].[Xe] VKDJIPBMRCGQMQ-UHFFFAOYSA-N 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 239000008363 phosphate buffer Substances 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 238000000862 absorption spectrum Methods 0.000 description 6
- 108010047754 beta-Glucosidase Proteins 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 6
- 238000006073 displacement reaction Methods 0.000 description 6
- 239000001307 helium Substances 0.000 description 6
- 229910052734 helium Inorganic materials 0.000 description 6
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 6
- 230000002706 hydrostatic effect Effects 0.000 description 6
- 102000030523 Catechol oxidase Human genes 0.000 description 5
- 108010031396 Catechol oxidase Proteins 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 108010015776 Glucose oxidase Proteins 0.000 description 5
- 239000004366 Glucose oxidase Substances 0.000 description 5
- 102000005731 Glucose-6-phosphate isomerase Human genes 0.000 description 5
- 108010070600 Glucose-6-phosphate isomerase Proteins 0.000 description 5
- OLBVUFHMDRJKTK-UHFFFAOYSA-N [N].[O] Chemical compound [N].[O] OLBVUFHMDRJKTK-UHFFFAOYSA-N 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000004364 calculation method Methods 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 229940116332 glucose oxidase Drugs 0.000 description 5
- 235000019420 glucose oxidase Nutrition 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000005070 sampling Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 4
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 4
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 4
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 4
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 239000012458 free base Substances 0.000 description 4
- 229960004502 levodopa Drugs 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 239000001272 nitrous oxide Substances 0.000 description 4
- 229910052704 radon Inorganic materials 0.000 description 4
- SYUHGPGVQRZVTB-UHFFFAOYSA-N radon atom Chemical compound [Rn] SYUHGPGVQRZVTB-UHFFFAOYSA-N 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 4
- 229940120668 salicin Drugs 0.000 description 4
- 239000012047 saturated solution Substances 0.000 description 4
- 229920002379 silicone rubber Polymers 0.000 description 4
- 239000004945 silicone rubber Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 238000000844 transformation Methods 0.000 description 4
- 108090000673 Ammonia-Lyases Proteins 0.000 description 3
- 102000004118 Ammonia-Lyases Human genes 0.000 description 3
- 244000144725 Amygdalus communis Species 0.000 description 3
- 240000006670 Chlorogalum pomeridianum Species 0.000 description 3
- 235000007836 Chlorogalum pomeridianum Nutrition 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 108090000279 Peptidyltransferases Proteins 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 235000020224 almond Nutrition 0.000 description 3
- 239000009895 amole Substances 0.000 description 3
- 210000003719 b-lymphocyte Anatomy 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 108010030844 2-methylcitrate synthase Proteins 0.000 description 2
- 210000003771 C cell Anatomy 0.000 description 2
- 108010071536 Citrate (Si)-synthase Proteins 0.000 description 2
- 102000006732 Citrate synthase Human genes 0.000 description 2
- 108010093096 Immobilized Enzymes Proteins 0.000 description 2
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 2
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 2
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 2
- 101100018717 Mus musculus Il1rl1 gene Proteins 0.000 description 2
- 108090001066 Racemases and epimerases Proteins 0.000 description 2
- 102000004879 Racemases and epimerases Human genes 0.000 description 2
- 101150006985 STE2 gene Proteins 0.000 description 2
- 208000010513 Stupor Diseases 0.000 description 2
- 239000012080 ambient air Substances 0.000 description 2
- 102000006995 beta-Glucosidase Human genes 0.000 description 2
- 230000005587 bubbling Effects 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000009189 diving Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000011067 equilibration Methods 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 239000008176 lyophilized powder Substances 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- VGEREEWJJVICBM-UHFFFAOYSA-N phloretin Chemical compound C1=CC(O)=CC=C1CCC(=O)C1=C(O)C=C(O)C=C1O VGEREEWJJVICBM-UHFFFAOYSA-N 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000010666 regulation of catalytic activity Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- WTFXTQVDAKGDEY-UHFFFAOYSA-N (-)-chorismic acid Natural products OC1C=CC(C(O)=O)=CC1OC(=C)C(O)=O WTFXTQVDAKGDEY-UHFFFAOYSA-N 0.000 description 1
- ZWTDXYUDJYDHJR-UHFFFAOYSA-N (E)-1-(2,4-dihydroxyphenyl)-3-(2,4-dihydroxyphenyl)-2-propen-1-one Natural products OC1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O ZWTDXYUDJYDHJR-UHFFFAOYSA-N 0.000 description 1
- NYPYHUZRZVSYKL-UHFFFAOYSA-N -3,5-Diiodotyrosine Natural products OC(=O)C(N)CC1=CC(I)=C(O)C(I)=C1 NYPYHUZRZVSYKL-UHFFFAOYSA-N 0.000 description 1
- WYFYSTBFFDOVJW-UHFFFAOYSA-L 2-[4-[4-(3,5-diphenyltetrazol-2-ium-2-yl)phenyl]phenyl]-3,5-diphenyltetrazol-2-ium;dichloride Chemical compound [Cl-].[Cl-].C1=CC=CC=C1C(N=[N+]1C=2C=CC(=CC=2)C=2C=CC(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=NN1C1=CC=CC=C1 WYFYSTBFFDOVJW-UHFFFAOYSA-L 0.000 description 1
- 108010052386 2-haloacid dehalogenase Proteins 0.000 description 1
- PMWATMXOQQZNBX-DKBZLLMOSA-N 2-methylcrotonoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C(/C)=C/C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 PMWATMXOQQZNBX-DKBZLLMOSA-N 0.000 description 1
- NYPYHUZRZVSYKL-ZETCQYMHSA-N 3,5-diiodo-L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC(I)=C(O)C(I)=C1 NYPYHUZRZVSYKL-ZETCQYMHSA-N 0.000 description 1
- 108030002044 3-hydroxyanthranilate oxidases Proteins 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 108010002945 Acetoin dehydrogenase Proteins 0.000 description 1
- 241000590020 Achromobacter Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 101001091423 Agaricus bisporus Polyphenol oxidase 2 Proteins 0.000 description 1
- 102000003677 Aldehyde-Lyases Human genes 0.000 description 1
- 108090000072 Aldehyde-Lyases Proteins 0.000 description 1
- 108010092760 Alliin lyase Proteins 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 108010032592 Azobenzene reductase Proteins 0.000 description 1
- 101000705994 Bombyx mori Phenoloxidase subunit 2 Proteins 0.000 description 1
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 1
- 241000178335 Caldicellulosiruptor saccharolyticus Species 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 102000004031 Carboxy-Lyases Human genes 0.000 description 1
- 108090000489 Carboxy-Lyases Proteins 0.000 description 1
- 108010035722 Chloride peroxidase Proteins 0.000 description 1
- 108010000898 Chorismate mutase Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 108090000175 Cis-trans-isomerases Proteins 0.000 description 1
- 102000003813 Cis-trans-isomerases Human genes 0.000 description 1
- 102000005870 Coenzyme A Ligases Human genes 0.000 description 1
- 241000252095 Congridae Species 0.000 description 1
- 108010031700 Cytochrome-c3 hydrogenase Proteins 0.000 description 1
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 1
- 108020005199 Dehydrogenases Proteins 0.000 description 1
- 102000048284 EC 6.3.3.- Human genes 0.000 description 1
- 108700034614 EC 6.3.3.- Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108020004206 Gamma-glutamyltransferase Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 101001091385 Homo sapiens Kallikrein-6 Proteins 0.000 description 1
- 108030003948 Hypotaurine dehydrogenases Proteins 0.000 description 1
- 102000005629 Intramolecular Oxidoreductases Human genes 0.000 description 1
- 108010084764 Intramolecular Oxidoreductases Proteins 0.000 description 1
- 108010031311 Intramolecular Transferases Proteins 0.000 description 1
- 102000005385 Intramolecular Transferases Human genes 0.000 description 1
- 102100034866 Kallikrein-6 Human genes 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 108010011449 Long-chain-fatty-acid-CoA ligase Proteins 0.000 description 1
- 102100038560 Maleylacetoacetate isomerase Human genes 0.000 description 1
- 101000606124 Margaritifera margaritifera Tyrosinase-like protein 2 Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 101710167853 N-methyltransferase Proteins 0.000 description 1
- YQHMWTPYORBCMF-UHFFFAOYSA-N Naringenin chalcone Natural products C1=CC(O)=CC=C1C=CC(=O)C1=C(O)C=C(O)C=C1O YQHMWTPYORBCMF-UHFFFAOYSA-N 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 241000041200 Nobia Species 0.000 description 1
- 102000004020 Oxygenases Human genes 0.000 description 1
- 108090000417 Oxygenases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108700018928 Peptide Synthases Proteins 0.000 description 1
- 102000056222 Peptide Synthases Human genes 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108700023158 Phenylalanine ammonia-lyases Proteins 0.000 description 1
- 101100333273 Phytophthora parasitica PARA1 gene Proteins 0.000 description 1
- 101000773106 Pinctada maxima Tyrosinase-like protein Proteins 0.000 description 1
- 241000589776 Pseudomonas putida Species 0.000 description 1
- 229910018503 SF6 Inorganic materials 0.000 description 1
- 101700004678 SLIT3 Proteins 0.000 description 1
- 102100027339 Slit homolog 3 protein Human genes 0.000 description 1
- 108010041155 Taurine dehydrogenase Proteins 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 1
- 108700015934 Triose-phosphate isomerases Proteins 0.000 description 1
- 108030004207 UDP-arabinose 4-epimerases Proteins 0.000 description 1
- 108060009212 Ureidoglycolate lyase Proteins 0.000 description 1
- 108030006907 Ureidosuccinases Proteins 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- GBXZONVFWYCRPT-JGWLITMVSA-N [(2r,3s,4r,5r)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl] dihydrogen phosphate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)OP(O)(O)=O GBXZONVFWYCRPT-JGWLITMVSA-N 0.000 description 1
- JXBFBSYDINUVRE-UHFFFAOYSA-N [Ne].[Ar] Chemical compound [Ne].[Ar] JXBFBSYDINUVRE-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 108010042363 alkylmercury lyase Proteins 0.000 description 1
- 230000003281 allosteric effect Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 230000002715 bioenergetic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000011138 biotechnological process Methods 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000019846 buffering salt Nutrition 0.000 description 1
- 235000021170 buffet Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 108010054909 carnosine synthetase Proteins 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 108010075269 chlorate reductase Proteins 0.000 description 1
- WTFXTQVDAKGDEY-HTQZYQBOSA-N chorismic acid Chemical compound O[C@@H]1C=CC(C(O)=O)=C[C@H]1OC(=C)C(O)=O WTFXTQVDAKGDEY-HTQZYQBOSA-N 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000013211 curve analysis Methods 0.000 description 1
- 108010018386 cytochrome cd1 Proteins 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000002242 deionisation method Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000006392 deoxygenation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- DMSHWWDRAYHEBS-UHFFFAOYSA-N dihydrocoumarin Natural products C1CC(=O)OC2=C1C=C(OC)C(OC)=C2 DMSHWWDRAYHEBS-UHFFFAOYSA-N 0.000 description 1
- 229960000415 diiodotyrosine Drugs 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- BCQZXOMGPXTTIC-UHFFFAOYSA-N halothane Chemical compound FC(F)(F)C(Cl)Br BCQZXOMGPXTTIC-UHFFFAOYSA-N 0.000 description 1
- 229960003132 halothane Drugs 0.000 description 1
- CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 1
- AFAUWLCCQOEICZ-UHFFFAOYSA-N helium xenon Chemical class [He].[Xe] AFAUWLCCQOEICZ-UHFFFAOYSA-N 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 210000001822 immobilized cell Anatomy 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000000937 inactivator Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- PDEXVOWZLSWEJB-UHFFFAOYSA-N krypton xenon Chemical compound [Kr].[Xe] PDEXVOWZLSWEJB-UHFFFAOYSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 108010035293 maleylacetoacetate isomerase Proteins 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- CSJDCSCTVDEHRN-UHFFFAOYSA-N methane;molecular oxygen Chemical compound C.O=O CSJDCSCTVDEHRN-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000007128 oxidoreductase reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000009931 pascalization Methods 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- HHJTWTPUPVQKNA-PIIMIWFASA-N psychosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O HHJTWTPUPVQKNA-PIIMIWFASA-N 0.000 description 1
- HHJTWTPUPVQKNA-UHFFFAOYSA-N psychosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)COC1OC(CO)C(O)C(O)C1O HHJTWTPUPVQKNA-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 108060007223 rubredoxin Proteins 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- SFZCNBIFKDRMGX-UHFFFAOYSA-N sulfur hexafluoride Chemical compound FS(F)(F)(F)(F)F SFZCNBIFKDRMGX-UHFFFAOYSA-N 0.000 description 1
- 229960000909 sulfur hexafluoride Drugs 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229960001005 tuberculin Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-L tyrosinate(2-) Chemical compound [O-]C(=O)C(N)CC1=CC=C([O-])C=C1 OUYCCCASQSFEME-UHFFFAOYSA-L 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/99—Enzyme inactivation by chemical treatment
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70658791A | 1991-05-28 | 1991-05-28 | |
| US706587 | 1991-05-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU1711692A AU1711692A (en) | 1992-12-03 |
| AU660675B2 true AU660675B2 (en) | 1995-07-06 |
Family
ID=24838243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU17116/92A Ceased AU660675B2 (en) | 1991-05-28 | 1992-05-25 | Method for regulating enzyme activities by noble gases |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US5462861A (en, 2012) |
| EP (1) | EP0516549B1 (en, 2012) |
| JP (1) | JP3655322B2 (en, 2012) |
| KR (1) | KR100226649B1 (en, 2012) |
| CN (1) | CN1037980C (en, 2012) |
| AR (1) | AR246982A1 (en, 2012) |
| AT (1) | ATE244301T1 (en, 2012) |
| AU (1) | AU660675B2 (en, 2012) |
| BR (1) | BR9202016A (en, 2012) |
| CA (1) | CA2069534A1 (en, 2012) |
| DE (1) | DE69233112T2 (en, 2012) |
| DK (1) | DK0516549T3 (en, 2012) |
| ES (1) | ES2202300T3 (en, 2012) |
| FI (1) | FI103984B1 (en, 2012) |
| HU (1) | HU214697B (en, 2012) |
| IL (1) | IL101996A (en, 2012) |
| MX (1) | MX9202486A (en, 2012) |
| PT (1) | PT516549E (en, 2012) |
| TW (1) | TW284788B (en, 2012) |
| ZA (1) | ZA923847B (en, 2012) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU666937B2 (en) * | 1992-04-03 | 1996-02-29 | L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude | Method for improving the aroma and/or the flavor of wine using noble gases |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2102779A1 (en) * | 1992-04-03 | 1993-10-04 | Kevin C. Spencer | A method of controlling the oxidation of chemicals during storage using noble gases |
| FR2742765B1 (fr) * | 1995-12-21 | 1998-02-13 | Armines | Procede d'inactivation irreversible d'enzymes en solution |
| US5693354A (en) * | 1996-05-01 | 1997-12-02 | L'air Liquide, Societe Anonyme Pour L'etude Et, L'exploitation Des Procedes Georges Claude | Method of disinfecting fresh vegetables by processing the same with a liquid containing a mixture of argon:carbon dioxide |
| US7297800B2 (en) * | 2001-12-27 | 2007-11-20 | Ajinomoto Co., Inc. | Process of producing glutamate derivatives |
| CA2714881C (en) | 2002-08-26 | 2012-10-23 | Ajinomoto Co., Inc. | Novel aldolase and production process of substituted .alpha.-keto acids |
| CA2507225C (en) | 2002-12-09 | 2012-02-07 | Ajinomoto Co., Inc. | Mutated d-aminotransferase and method for producing optically active glutamic acid derivatives using the same |
| JP4944018B2 (ja) * | 2004-06-07 | 2012-05-30 | ノボザイムス アクティーゼルスカブ | 脂肪分解酵素アッセイ |
| US7180370B2 (en) * | 2004-09-01 | 2007-02-20 | Micron Technology, Inc. | CMOS amplifiers with frequency compensating capacitors |
| US8394624B2 (en) * | 2009-01-30 | 2013-03-12 | American Air Liquide, Inc. | Process for preserving biological materials for extended periods of time |
| WO2017035253A1 (en) | 2015-08-24 | 2017-03-02 | The Regents Of The University Of California | Methods and compositions for protein purification and enzyme reaction |
Family Cites Families (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE635601C (de) * | 1933-08-01 | 1936-09-21 | Francesco Illy | Verfahren zum Frischhalten von geroestetem, gegebenenfalls gemahlenem Kaffee |
| GB415656A (en) * | 1934-02-17 | 1934-08-30 | Francesco Illy | Improved processes for preserving roasted or roasted and ground coffee |
| US2569217A (en) * | 1949-05-02 | 1951-09-25 | Aram A Arabian | Method and package for preserving food |
| US3143471A (en) * | 1962-01-18 | 1964-08-04 | Merck & Co Inc | Argon method of drying and preserving lyophilized therapeutic products |
| US3183171A (en) * | 1962-07-24 | 1965-05-11 | Union Carbide Corp | Process for controlling the growth rate of fungi |
| FR1339669A (fr) * | 1962-08-31 | 1963-10-11 | Air Liquide | Procédé de stabilisation de produits altérables à l'air |
| FR1454653A (fr) * | 1964-10-29 | 1966-02-11 | Yissum Res Dev Co | Procédé de production de peptides |
| US3378443A (en) * | 1966-04-05 | 1968-04-16 | American Cyanamid Co | Anhydrous liquid suspensions of biologics |
| US4044004A (en) * | 1968-11-22 | 1977-08-23 | Hoffmann-La Roche Inc. | Total steroid synthesis employing substituted isoxazole derivatives |
| US3677024A (en) * | 1970-01-20 | 1972-07-18 | Paul E Segall | Preservation and storage of biologic materials |
| US3725076A (en) * | 1970-12-21 | 1973-04-03 | Gen Foods Corp | Coffee of improved aroma and freshness retention |
| FR2194418B2 (en, 2012) * | 1971-08-02 | 1977-01-28 | Sada Pietro | |
| BE787573A (fr) * | 1971-10-22 | 1973-02-14 | Hag Ag | Procede de fabrication de poudres ayant la couleur de la substance de depart, a partir d'extraits aqueux de produits vegetaux par lyophilisation |
| FR2225095A1 (en) * | 1973-04-11 | 1974-11-08 | Inst Scient Tech Alimentat | Packaging roasted coffee in gas-tight packets - with preservative gas to assist aroma retention |
| US3957892A (en) * | 1973-05-23 | 1976-05-18 | Ethyl Corporation | Stabilized vinylidene halide |
| FR2261518A1 (en) * | 1974-02-20 | 1975-09-12 | Commissariat Energie Atomique | Removal and storage of sodium products - transfer from sealed container for storage in neutral atmosphere |
| DE2437812C3 (de) * | 1974-08-06 | 1980-06-26 | Messer Griesheim Gmbh, 6000 Frankfurt | Verfahren zum Konservieren isolierter Organe oder Organteile |
| US4138565A (en) * | 1975-05-31 | 1979-02-06 | Sandoz Ltd. | Stable solutions and processes for their preparation |
| US4017363A (en) * | 1975-12-19 | 1977-04-12 | Novo Industri A/S | Production of high purity glucose syrups |
| JPS5286987A (en) * | 1976-01-14 | 1977-07-20 | Mitsubishi Gas Chem Co Inc | Disoxidant composition |
| JPS607609B2 (ja) * | 1976-02-10 | 1985-02-26 | 東亞合成株式会社 | α―シアノアクリル酸エステルの貯蔵方法 |
| JPS5319998A (en) * | 1976-08-09 | 1978-02-23 | Toda Kogyo Corp | Process for preparing cobalttdoped acicular magnetite particle having magnetic stability |
| FR2406567A1 (fr) * | 1977-10-24 | 1979-05-18 | Dubois Jacques | Procede et dispositif destines a l'emballage etanche sous film thermoplastique et thermoformable de produits exigeant une protection absolue |
| JPS54129185A (en) * | 1978-03-30 | 1979-10-06 | Unitika Ltd | Storing of immobilized enzyme |
| JPS5516A (en) * | 1978-05-08 | 1980-01-05 | Ajinomoto Co Inc | Production of high concentration dextrin solution |
| FR2431860A1 (fr) * | 1978-07-27 | 1980-02-22 | Oreal | Lyophilisats de melanges reactionnels en milieu anaerobie de polhydroxybenzenes et de precurseurs de colorants par oxydation de type para, leur procede de preparation et leur utilisation dans des compositions tinctoriales pour cheveux |
| US4501814A (en) * | 1978-10-26 | 1985-02-26 | The Amalgamated Sugar Company | Process for producing a high fructose sweetener, high protein meal, and cereal germ oils |
| FR2463780A1 (fr) * | 1979-08-24 | 1981-02-27 | Rhone Poulenc Ind | Procede de preparation de solutions aqueuses d'acides polyacryliques de faibles masses moleculaires ou de leurs sels |
| DE3007712C2 (de) * | 1980-02-29 | 1983-12-15 | Rheinmetall GmbH, 4000 Düsseldorf | Verpackung für Treibladungspulver, Treibladungen oder verbrennbare Munitionsformteile |
| US4315266A (en) * | 1980-07-25 | 1982-02-09 | Nasa | Spiral slotted phased antenna array |
| US4308264A (en) * | 1981-01-28 | 1981-12-29 | Abbott Laboratories | Stabilized, dilute aqueous preparation of 1α,25-dihydroxycholecalciferol for neonatal administration |
| JPS5839650A (ja) * | 1981-09-04 | 1983-03-08 | Nippon Kasei Kk | Ｄ−２−アミノ−２−（１，４−シクロヘキサジエニル）酢酸の保存方法 |
| JPS58107180A (ja) * | 1981-12-17 | 1983-06-25 | Matsushita Electric Ind Co Ltd | 固定化酵素膜の保存方法 |
| US4450960A (en) * | 1982-08-30 | 1984-05-29 | Empak Inc. | Package |
| JPS5984719A (ja) * | 1982-10-30 | 1984-05-16 | テルモ株式会社 | 長期間変質することのない薬液入りプラスチツク容器の製造方法 |
| EP0111595A1 (en) * | 1982-12-22 | 1984-06-27 | Dow Chemical (Belgium) S.A. | Improved method for the production of high fructose corn syrup |
| JPS6056984A (ja) * | 1983-09-06 | 1985-04-02 | Nippon Youriyokuso Kk | 天然クロロフィルの製造法 |
| US4664256A (en) * | 1983-09-06 | 1987-05-12 | Farmaceutisk Laboratorium Ferring A/S | Packaged stable enema solution or suspension containing 5-aminosalicyclic acid |
| US4496397A (en) * | 1984-03-07 | 1985-01-29 | University Of Connecticut | Process for purifying and stabilizing catechol-containing proteins and materials obtained thereby |
| SU1289437A1 (ru) * | 1984-08-20 | 1987-02-15 | Казахский научно-исследовательский институт клинической и экспериментальной хирургии им.А.Н.Сызганова | Способ консервации изолированных клеток печени |
| US4830858A (en) * | 1985-02-11 | 1989-05-16 | E. R. Squibb & Sons, Inc. | Spray-drying method for preparing liposomes and products produced thereby |
| US4643976A (en) * | 1985-06-03 | 1987-02-17 | Ciba Corning Diagnostics Corp. | Liquid clinical control, standard, and reagent products |
| US4812320A (en) * | 1986-05-05 | 1989-03-14 | Geo. A. Hormel & Co. | Process for vacuum packaging fresh meat products |
| JPS6377848A (ja) * | 1986-09-19 | 1988-04-08 | Kohjin Co Ltd | Ｎ，ｎ−ジアルキルアミノプロピル型化合物の安定化法 |
| WO1988007676A1 (en) * | 1987-03-27 | 1988-10-06 | Terumo Kabushiki Kaisha | Enzyme sensor |
| CA1301533C (en) * | 1987-03-31 | 1992-05-26 | William Duncan Powrie | Preservation of cut and segmented fresh fruit pieces |
| CH672996A5 (en, 2012) * | 1987-06-26 | 1990-01-31 | Battelle Memorial Institute | |
| JPS6459647A (en) * | 1987-08-31 | 1989-03-07 | Nippon Denki Home Electronics | Objective lens actuator for optical head |
| US4919955A (en) * | 1987-09-08 | 1990-04-24 | Mitchell Jerry L | Method for packaging perishable products |
| FR2627696B1 (fr) * | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | Nouvelle forme galenique du fenofibrate |
| US4892579A (en) * | 1988-04-21 | 1990-01-09 | The Dow Chemical Company | Process for preparing an amorphous alloy body from mixed crystalline elemental metal powders |
| US5108656A (en) * | 1988-06-07 | 1992-04-28 | American Air Liquide | Method for preservation of fresh fish or sea-food |
| US4946326A (en) * | 1988-06-07 | 1990-08-07 | American Air Liquide | Method for preservation of fresh fish or sea-food |
| JPH02104502A (ja) * | 1988-10-13 | 1990-04-17 | Nippon Nohyaku Co Ltd | 水中懸濁状農薬組成物 |
| FR2643232A1 (fr) * | 1988-12-16 | 1990-08-24 | Mansour Robert | Methode de protection de beaucoup d'articles durant les periodes de stockage et de conservation, par l'emploi de l'evacuation de l'air suivie par le passage de gaz inerte dans un cycle clos |
| US5045529A (en) * | 1989-03-27 | 1991-09-03 | Bionostics, Inc. | Tonometric fluid for blood gas and co-oximetry instruments |
| US4965165A (en) * | 1989-05-30 | 1990-10-23 | The Mead Corporation | Donor media shelf life stabilization by control of exposure to contacting oxygen and moisture |
| JPH0357689A (ja) * | 1989-07-25 | 1991-03-13 | Brother Ind Ltd | 顕色剤シートの保存方法及び梱包方法 |
| FR2652719B1 (fr) * | 1989-10-05 | 1996-07-19 | Air Liquide | Procede de traitement de conservation de produits alimentaires vegetaux frais. |
| JPH03200568A (ja) * | 1989-12-28 | 1991-09-02 | Sanden Corp | オイル保管用容器 |
| FI102543B (fi) * | 1990-01-04 | 1998-12-31 | Plant Genetic Systems Nv | Mutantti glukoosi-isomeraasit |
| US4971813A (en) * | 1990-02-13 | 1990-11-20 | The Procter & Gamble Company | Process for making concentrated low calorie fruit juice |
| US5006222A (en) * | 1990-05-23 | 1991-04-09 | Texaco Inc. | Solvent dewaxing of lubricating oils |
| US5030778A (en) * | 1990-06-04 | 1991-07-09 | Ethyl Corporation | Decabromodiphenyl alkane process |
| US5021251A (en) * | 1990-07-23 | 1991-06-04 | Borden, Inc. | Process for preserving lemon juice utilizating a non-sulfite preservative |
| JPH05227699A (ja) * | 1992-02-18 | 1993-09-03 | Aisin Seiki Co Ltd | アクチュエータ装置 |
-
1992
- 1992-05-15 TW TW081103785A patent/TW284788B/zh active
- 1992-05-25 AU AU17116/92A patent/AU660675B2/en not_active Ceased
- 1992-05-25 FI FI922385A patent/FI103984B1/fi active
- 1992-05-26 KR KR1019920008922A patent/KR100226649B1/ko not_active Expired - Fee Related
- 1992-05-26 AR AR92322399A patent/AR246982A1/es active
- 1992-05-26 IL IL101996A patent/IL101996A/xx not_active IP Right Cessation
- 1992-05-26 MX MX9202486A patent/MX9202486A/es not_active IP Right Cessation
- 1992-05-26 CA CA002069534A patent/CA2069534A1/en not_active Abandoned
- 1992-05-26 ZA ZA923847A patent/ZA923847B/xx unknown
- 1992-05-27 CN CN92103909A patent/CN1037980C/zh not_active Expired - Fee Related
- 1992-05-27 BR BR929202016A patent/BR9202016A/pt not_active Application Discontinuation
- 1992-05-27 JP JP16046092A patent/JP3655322B2/ja not_active Expired - Fee Related
- 1992-05-27 HU HU9201767A patent/HU214697B/hu not_active IP Right Cessation
- 1992-05-29 DE DE69233112T patent/DE69233112T2/de not_active Expired - Fee Related
- 1992-05-29 ES ES92401470T patent/ES2202300T3/es not_active Expired - Lifetime
- 1992-05-29 PT PT92401470T patent/PT516549E/pt unknown
- 1992-05-29 AT AT92401470T patent/ATE244301T1/de not_active IP Right Cessation
- 1992-05-29 DK DK92401470T patent/DK0516549T3/da active
- 1992-05-29 EP EP92401470A patent/EP0516549B1/en not_active Expired - Lifetime
-
1993
- 1993-05-17 US US08/062,332 patent/US5462861A/en not_active Expired - Lifetime
-
1995
- 1995-05-22 US US08/445,525 patent/US5707842A/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU666937B2 (en) * | 1992-04-03 | 1996-02-29 | L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude | Method for improving the aroma and/or the flavor of wine using noble gases |
Also Published As
| Publication number | Publication date |
|---|---|
| FI103984B (fi) | 1999-10-29 |
| HUT64585A (en) | 1994-01-28 |
| IL101996A (en) | 1997-07-13 |
| ES2202300T3 (es) | 2004-04-01 |
| FI922385L (fi) | 1992-11-29 |
| DE69233112D1 (de) | 2003-08-07 |
| CN1068369A (zh) | 1993-01-27 |
| AU1711692A (en) | 1992-12-03 |
| DK0516549T3 (da) | 2003-10-27 |
| HU214697B (hu) | 1998-04-28 |
| PT516549E (pt) | 2003-11-28 |
| KR100226649B1 (ko) | 1999-10-15 |
| HU9201767D0 (en) | 1992-08-28 |
| EP0516549A3 (en) | 1993-06-09 |
| JPH05328968A (ja) | 1993-12-14 |
| JP3655322B2 (ja) | 2005-06-02 |
| DE69233112T2 (de) | 2004-04-15 |
| US5707842A (en) | 1998-01-13 |
| FI103984B1 (fi) | 1999-10-29 |
| ZA923847B (en) | 1993-01-27 |
| CN1037980C (zh) | 1998-04-08 |
| IL101996A0 (en) | 1992-12-30 |
| TW284788B (en, 2012) | 1996-09-01 |
| EP0516549A2 (en) | 1992-12-02 |
| BR9202016A (pt) | 1993-01-26 |
| AR246982A1 (es) | 1994-10-31 |
| US5462861A (en) | 1995-10-31 |
| FI922385A0 (fi) | 1992-05-25 |
| MX9202486A (es) | 1992-11-01 |
| ATE244301T1 (de) | 2003-07-15 |
| EP0516549B1 (en) | 2003-07-02 |
| CA2069534A1 (en) | 1992-11-29 |
| KR920021707A (ko) | 1992-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU660675B2 (en) | Method for regulating enzyme activities by noble gases | |
| Vallee et al. | The metallobiochemistry of zinc enzymes | |
| Pompliano et al. | Stabilization of a reaction intermediate as a catalytic device: definition of the functional role of the flexible loop in triosephosphate isomerase | |
| Chen et al. | Inhibition of β-lactamase by clavulanate: trapped intermediates in cryocrystallographic studies | |
| van Tol et al. | Do organic solvents affect the catalytic properties of lipase? Intrinsic kinetic parameters of lipases in ester hydrolysis and formation in various organic solvents | |
| Juszczak et al. | The extremely thermophilic eubacterium, Thermotoga maritima, contains a novel iron-hydrogenase whose cellular activity is dependent upon tungsten | |
| Xu et al. | Transition state stabilization of subtilisins in organic media | |
| Roppongi et al. | Crystal structures of a bacterial dipeptidyl peptidase IV reveal a novel substrate recognition mechanism distinct from that of mammalian orthologues | |
| Livingston et al. | 8-hydroxy-5-deazaflavin-reducing hydrogenase from methanobacterium thermoautotrophicum: 2. Kinetic and hydrogen-transfer studies. Derivation of a steady-state rate equation for deazaflavin-reducing hydrogenase | |
| Petsko et al. | Observation of unstable species in enzyme-catalyzed transformations using protein crystallography | |
| Kaczorowski et al. | Coupling of alanine racemase and D-alanine dehydrogenase to active transport of amino acids in Escherichia coli B membrane vesicles. | |
| Wangikar et al. | Probing enzymic transition state hydrophobicities | |
| Kim et al. | Pressure affects enzyme function in organic media | |
| Dobbek | Mechanism of Ni, Fe-Containing carbon monoxide dehydrogenases | |
| Kinoshita et al. | Factors influencing enantioselectivity of lipase-catalyzed hydrolysis | |
| Tsotsou et al. | Biochemical characterisation of recombinant Streptomyces pristinaespiralis L-lysine cyclodeaminase | |
| Gupta et al. | Enzymology: early insights | |
| US5364777A (en) | Method of improving lipase activity using noble gases | |
| Kim et al. | Stability and sulfur‐reduction activity in non‐aqueous phase liquids of the hydrogenase from the hyperthermophile Pyrococcus furiosus | |
| Ogino | Organic solvent-stable enzymes | |
| Bazzone et al. | Bovine procarboxypeptidase A: kinetics of peptide and ester hydrolysis | |
| Garcia et al. | Metal ion dependence of phosphorothioate atp analogs in the bacillus stearothermophilus tyrosyl-trna synthetase | |
| Takaki et al. | Streptomyces griseus enhances denitrification by Ralstonia pickettii K50, which is possibly mediated by histidine produced during co-culture | |
| Lange III et al. | Substrate enantiomers. Modifiers of carboxypeptidase A activity | |
| Versari et al. | Enzymatic hydrolysis of nitrides by an engineered nitrile hydratase (Papain Gln19Glu) in aqueous‐organic media |